Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Biotech
Biotech
Page 3 of 19
Tech
Tech Reporter
By
Sharon Goldman
June 25, 2024
Commentary
Verge Genomics CEO: Why I urge my employees to share their fears and vulnerabilities—and do the same with them
By
Alice Zhang
June 5, 2024
Newsletters
Tech Reporter
By
Sheryl Estrada
May 9, 2024
Newsletters
AI for drug discovery draws a $1 billion launch—and a lot of hope
By
Sage Lazzaro
April 25, 2024
Politics
U.S. lawmakers are trying to bar Chinese biotech companies over fears about America’s failure to compete with China in the industry
By
Didi Tang
and
The Associated Press
February 19, 2024
Newsletters
Exclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trials
By
Allie Garfinkle
February 6, 2024
Conferences
AI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’
By
Sage Lazzaro
December 14, 2023
Features
Evofem, the startup trying to survive the broken birth-control market, finally sells itself
By
Maria Aspan
December 13, 2023
Health
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By
Angel Adegbesan
and
Bloomberg
October 13, 2023
Politics
How Vivek Ramaswamy, the surprise GOP debate star, made his fortune and triggered his critics
By
Paolo Confino
August 24, 2023
Features
The Moderna COVID-19 vaccine was the ultimate home run for this biotech venture firm. It’s a tough act to follow
By
Paolo Confino
August 10, 2023
Leadership
Inside Illumina’s $8 billion deal that spurred a proxy fight with Carl Icahn and the ouster of 2 prominent Black Silicon Valley executives
By
Lila MacLellan
July 27, 2023
Finance
The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%
By
Angel Adegbesan
and
Bloomberg
July 12, 2023
Finance
Illumina CEO Francis deSouza resigns after proxy battle with Carl Icahn
By
Tiago Ramos Alfaro
and
Bloomberg
June 11, 2023
Newsletters
Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
By
Lucy Brewster
May 24, 2023
Most Popular
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30...
By
Eleanor Pringle
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By
Jim Edwards
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By
Jordan Blum